JUUL Lawsuit Settlement Nets Millions for Schools

Mar.22.2023
JUUL Lawsuit Settlement Nets Millions for Schools
Florida school board approves multi-million dollar settlement from JUUL lawsuit.

On March 21st, according to a report by Fox 13 News, Hillsborough County School Board members in Florida are expected to approve a settlement agreement with JUUL that will include compensation for the school. The funds, which are projected to reach millions of dollars and will be paid over the course of several years, are expected to be approved on Tuesday.


A settlement of $440 million.


In September 2022, the Attorney General of Connecticut announced that JUUL has agreed to pay nearly $440 million to settle over 30 lawsuits from several states concerning their high-nicotine electronic cigarette products. Following this, over 1300 school districts in the United States are currently learning about the settlement amounts they will receive.


To participate in a lawsuit claim, a school district must fulfill two requirements: the school must agree to divide 25% of the compensation with participating lawyers, and the school must provide information about the impact of e-cigarettes in their region.


A series of lawsuits has accused JUUL of using deceptive marketing strategies that target young people and harm their health with nicotine-infused e-cigarettes. The accusations also include school administrators being burdened with financial, time, and resource costs as a result of dealing with student addiction.


Previously, Frederick Hyde, the mayor of Polk County, stated that when school administrators conducted random searches, the item they found most frequently was electronic cigarettes. "Faced with the well-known screening before entering the building, students threw away the most electronic cigarettes in the trash cans in front of the school.


It has been reported that in early March, another Florida-based public school, Orange County, learned that it would receive $5.4 million from the settlement. A member of the Orange County school board stated that they intend to use this money to buy electronic cigarette detectors to protect students. They also plan to offer counseling to students who use e-cigarettes.


JUUL still faces lawsuits to contend with.


Since 2019, JUUL has been maintaining a low profile. It has abandoned all American advertising and removed its fruit and candy flavored e-cigarettes from store shelves.


The FDA took action in June 2022 by issuing a marketing ban on all JUUL products sold in the United States.


Subsequently, JUUL questioned this ruling in court. Afterwards, the FDA conducted a scientific review of the company's technology once again.


According to exclusive information compiled by 2FIRSTS, JUUL has paid a total of $2.6376 billion (approximately 18.2 billion RMB) in settlement funds and is still facing nine independent lawsuits from other states. Additionally, the company is also facing hundreds of individual lawsuits brought forth by teenagers and others.


Related reading:


JUUL has paid $18.2 billion in settlements as part of its effort to resolve ongoing legal issues. This article lists the settlement amounts and conditions in various states.


The American brand Juul will pay $440 million to reach a settlement with various states.


A US district court has approved a $255 million settlement for a class-action lawsuit against Juul prior to the start of the trial.


E-cigarette company JUUL has paid out $1.7 billion in settlements, following lawsuits from 34 different US states.


References:


Hillsborough County schools may be awarded millions of dollars as a result of a lawsuit filed against JUUL.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Former cigarette smokers accounted for an estimated 54% of current e-cigarette users in Great Britain in 2025, while 26% also smoked cigarettes and 20% had never regularly smoked, according to a 2Firsts analysis of Office for National Statistics (ONS) data. Among former cigarette smokers who currently vape, approximately 81% used e-cigarettes daily, compared with about 50% of dual users. The ONS found that 33.8% of current cigarette smokers also vaped in 2025, up from 10.6% in 2014. Approximately 1.1 million adults who had never regularly smoked cigarettes used e-cigarettes, representing 2.9% of that population, compared with 0.2% in 2014. The figures highlight differences in the composition, frequency of use and long-term trends across Britain's vaping population.
DATA
Oct.14
Iowa Sets November 16 Vape Directory Launch: Unlisted Products Face Sales Ban, Manufacturers $1,000 Daily Fines per Product
Iowa Sets November 16 Vape Directory Launch: Unlisted Products Face Sales Ban, Manufacturers $1,000 Daily Fines per Product
Iowa plans to publish its first vapor products directory on November 16, 2026, after which products not listed will be prohibited from sale or offer for sale in the state. The Department of Revenue expects to begin penalty enforcement on December 17, following an initial 21-business-day period focused on compliance education. Under House File 2677, retailers, distributors and wholesalers selling unlisted products face civil penalties of $300 per product per day, while manufacturers face $1,000 per product per day. Eligibility extends to FDA-authorized products and certain products meeting historical marketing and pending PMTA requirements. The directory program resumed after a federal appeals court vacated a preliminary injunction in July 2026.
Regulations
Nov.05
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
On September 16, 2Firsts hosted a China-focused industry forum during InterTabac in Dortmund, bringing together more than 30 participants from North America, Europe, India, South Korea and other markets. The session covered traditional tobacco, next-generation products, exports, technology, regulation and supply chains, while examining how China’s tobacco sector operates, where its transformation may be heading, and why its growing role matters increasingly to companies across the global tobacco and nicotine industry.
Sep.21
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Philip Morris Korea launched TEREA ONYX, a new tobacco stick line for IQOS ILUMA devices, on October 15, 2026. The initial products, AMANG PEARL and CALI PEARL, feature tropical-inspired flavors, Fresh Filters and capsules designed to deliver different flavor experiences before and after activation. Both are priced at KRW 4,800 per pack and are available at convenience stores nationwide and IQOS-operated stores in South Korea. The launch expands the Korean TEREA portfolio from four product lines to five, following earlier capsule tobacco stick additions in 2026.
product
Oct.23
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26